Patent Number: 7,101,551

Title: Remedies for hepatitis C

Abstract: The present invention provides a substance which inhibits the binding between E2/NS1 protein of hepatitis C virus and a cell infectious with hepatitis C virus, a cell expressing CD81, or CD81. The present invention can provide a novel medicament which has an anti-viral effects such as an inhibitory action against HCV infection.

Inventors: Itami; Seima (Tokyo, JP), Shibui; Tatsurou (Tokyo, JP), Seki; Makoto (Tokyo, JP), Yotsumoto; Yoshihisa (Tokyo, JP), Matsuura; Yoshiharu (Osaka, JP), Miyamura; Tatsuo (Tokyo, JP)

Assignee: Mitsubishi Pharma Corporation

International Classification: A61K 39/42 (20060101); C12P 21/08 (20060101); A61K 39/12 (20060101); C12P 21/04 (20060101); G01N 33/53 (20060101)

Expiration Date: 9/05/02018